Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
New evidence

Meta-analysis links lactoferrin to 44% lower odds of diarrhea in children — but the trials weren't blinded and the evidence is still thin.

This is the first meta-analysis to suggest lactoferrin may help prevent diarrhea in kids, but because the included studies were unblinded and the overall evidence is still sparse, the result should be considered preliminary.

A new meta-analysis of pediatric studies found that supplementing with lactoferrin was associated with a 44% reduction in the odds of developing diarrhea (OR: 0.56; 95% CI: 0.41–0.75). However, the results come from unblinded trials — meaning participants and researchers knew who got the supplement — and the analysis did not find a benefit for upper respiratory infections. Because this is one of the first rigorous looks at lactoferrin for this purpose, the findings need to be confirmed in larger, blinded studies.

Where this fits in the evidence

This is among the first studies we've indexed on Lactoferrin for Reduced Diarrhea — treat it as an early signal until more research accumulates.

The study

Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis.

  • Meta-Analysis
  • 2025-01-01
  • Biochemistry and cell biology = Biochimie et biologie cellulaire

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top